Lv11
48 积分 2024-11-07 加入
The Relaxin Family Peptide Receptor 1 (RXFP1) Agonists as Potential Treatment for Heart Failure
4小时前
待确认
Efficacy and safety of aldosterone synthase inhibition with and without empagliflozin for chronic kidney disease: a randomised, controlled, phase 2 trial
1个月前
已完结
CS-3150, a novel non-steroidal mineralocorticoid receptor antagonist, prevents hypertension and cardiorenal injury in Dahl salt-sensitive hypertensive rats
1个月前
已完结
Three new epoxy-spirolactone derivatives: characterization in vivo and in vitro
2个月前
已关闭
Finerenone’s Promise in Heart Failure and Kidney Disease
2个月前
已完结
A four-in-one first-in-human study to assess safety, tolerability, pharmacokinetics, pharmacodynamics, and concentration-QTc relationship of HRS-1780, a selective non-steroidal mineralocorticoid receptor antagonist, in healthy men
2个月前
已完结
Finerenone, a Novel Selective Nonsteroidal Mineralocorticoid Receptor Antagonist Protects From Rat Cardiorenal Injury
2个月前
已完结
Non-steroidal mineralocorticoid receptor antagonists in cardiorenal disease
2个月前
已完结
Macrophage polarization in cancer and beyond: from inflammatory signaling pathways to potential therapeutic strategies
2个月前
已完结
Promoting proteostasis by cAMP/PKA and cGMP/PKG
3个月前
已完结
皖公网安备34019202002308
